Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria

被引:48
作者
Lorenzo, Victor [1 ]
Saracho, Ramon [2 ]
Zamora, Javier [3 ]
Rufino, Margarita [1 ]
Torres, Armando [4 ]
机构
[1] Hosp Univ Canarias, Nephrol Sect, San Cristobal la Laguna, Spain
[2] Hosp Santiago, Div Nephrol, Vitoria, Alava, Spain
[3] Hosp Ramon & Cajal, Biostat Unit, E-28034 Madrid, Spain
[4] Hosp Univ Canarias, Res Unit, Santa Cruz de Tenerife, Spain
关键词
albuminuria; chronic kidney disease; diabetes; renal disease progression; CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; PROGRESSION; RISK; NEPHROPATHY; PREDICTORS; PROTEINURIA; IMPAIRMENT; MODERATE;
D O I
10.1093/ndt/gfp475
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Methods. In this observational study, 333 patients (age 67 +/- 15 years, 46% diabetics) were included during a 7.5-year period. The mean follow-up was 30 +/- 18 months (range 4-79). The influence of study variables was evaluated applying a time-dependent Cox model and slope-based outcome using a linear regression model. Results. The diabetes condition was associated with adverse outcome in univariate analysis, and after adjusting for age, sex and systolic blood pressure. However, when controlling for albuminuria (a time-dependent covariate), diabetes did not show any association with outcome. In addition, the mean slope of renal decline was similar in diabetic and non-diabetic patients when controlling for albuminuria. The urinary albumin-creatinine ratio was a robust predictor of poor outcome in uni- and multivariate models. In the diabetic group, time-varying glycosilated haemoglobin did not influence renal outcome in the Cox model, and time-varying albuminuria remained a strong predictor of outcome. Conclusions. Diabetic patients have a poorer renal outcome, but at comparable levels of albuminuria renal decline is similar in diabetic and non-diabetic patients. Albuminuria is a risk factor for renal decline, and the main target to delay progression in patients, diabetics or non-diabetics, with moderate to advanced CKD.
引用
收藏
页码:835 / 841
页数:7
相关论文
共 32 条
[21]   A METHOD FOR ESTIMATING NITROGEN INTAKE OF PATIENTS WITH CHRONIC RENAL-FAILURE [J].
MARONI, BJ ;
STEINMAN, TI ;
MITCH, WE .
KIDNEY INTERNATIONAL, 1985, 27 (01) :58-65
[22]   PROTEINURIA, RENAL IMPAIRMENT, METABOLIC CONTROL, AND BLOOD-PRESSURE IN TYPE-2 DIABETES-MELLITUS - A 14-YEAR FOLLOW-UP REPORT ON 195 PATIENTS [J].
RAVID, M ;
SAVIN, H ;
LANG, R ;
JUTRIN, I ;
SHOSHANA, L ;
LISHNER, M .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (06) :1225-1229
[23]   Normoalbuminuric renal-insufficient diabetic patients - A lower-risk group [J].
Rigalleau, Vincent ;
Lasseur, Catherine ;
Raffaitin, Christelle ;
Beauvieux, Marie-Christine ;
Barthe, Nicole ;
Chauveau, Philippe ;
Combe, Christian ;
Gin, Henri .
DIABETES CARE, 2007, 30 (08) :2034-2039
[24]   Progression of nephropathy in type 2 diabetic patients [J].
Rossing, K ;
Christensen, PK ;
Hovind, P ;
Tarnow, L ;
Rossing, P ;
Parving, HH .
KIDNEY INTERNATIONAL, 2004, 66 (04) :1596-1605
[25]  
Ruggenenti P, 1997, LANCET, V349, P1857
[26]   Retarding progression of chronic renal disease: The neglected issue of residual proteinuria [J].
Ruggenenti, P ;
Perna, A ;
Remuzzi, G .
KIDNEY INTERNATIONAL, 2003, 63 (06) :2254-2261
[27]   Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies [J].
Ruggenenti, P ;
Perna, A ;
Mosconi, L ;
Pisoni, R ;
Remuzzi, G .
KIDNEY INTERNATIONAL, 1998, 53 (05) :1209-1216
[28]   Role of remission clinics in the longitudinal treatment of CKD [J].
Ruggenenti, Piero ;
Perticucci, Elena ;
Cravedi, Paolo ;
Gambara, Vincenzo ;
Costantini, Marco ;
Sharma, Sanjib Kumar ;
Perna, Annalisa ;
Remuzzi, Giuseppe .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (06) :1213-1224
[29]   Predicting initiation and progression of chronic kidney disease: Developing renal risk scores [J].
Taal, M. W. ;
Brenner, B. M. .
KIDNEY INTERNATIONAL, 2006, 70 (10) :1694-1705
[30]  
*USRDS, 2007, ANN DAT REP ATL END